Dr Daniel Metcalf

Biochemist
Medical Science Liaison Director

Dr Daniel Metcalf is a biochemist with a PhD in microbiology (medical biofilm therapy).

He has served the wound care industry for 22 years, and during 20 years at Convatec has supported and developed infection and wound management technologies such as FlexiSeal®, Aquacel® Ag, Aquacel® Ag+ Extra, InnovaMatrix®, and ConvaNiox™.

Holding a number of patents, he has received several international awards of recognition, and published approximately 30 papers on wound biofilm and wound care technologies.

Daniel has recently been appointed as Convatec’s first Medical Science Liaison Director having previously been R&D Director in Convatec’s Advanced Wound Care business.

Are all Antimicrobial Dressings the Same? Clinical Study Data on Two Novel Antibiofilm Dressing Technologies

Join Rebecca Rodger and Dr. Daniel Metcalf as they explore the science behind biofilm in hard-to-heal wounds and why not all antimicrobial dressings deliver the same outcomes.

This session will cover:

• • The role of biofilm in delayed healing and strategies for effective biofilm management.
  • Evidence from real-world practice and randomised controlled trials comparing standard of care to:
    • An antibiofilm silver Hydrofiber dressing.
    • A new nitric oxide-generating dressing for diabetic foot ulcers.
    • Practical insights on optimising silver dressing use, including the “two-week challenge”.

Delegates will leave with actionable knowledge to improve clinical decision-making and patient outcomes in foot and ankle wound care.